# Impact of Ketamine On Depressive Symptoms In Patients Undergoing Lumbo-peritoneal Shunt Insertion

> **NCT06060210** · PHASE4 · COMPLETED · sponsor: **Benha University** · enrollment: 110 (actual)

## Conditions studied

- Depression, Anxiety

## Interventions

- **DRUG:** normal Saline
- **DRUG:** Ketamine

## Key facts

- **NCT ID:** NCT06060210
- **Lead sponsor:** Benha University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-29
- **Primary completion:** 2025-09-01
- **Final completion:** 2025-11-01
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2026-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06060210

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06060210, "Impact of Ketamine On Depressive Symptoms In Patients Undergoing Lumbo-peritoneal Shunt Insertion". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06060210. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*